Overview

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine whether sumanirole, at three different dose levels, is effective and safe in the treatment of the signs and symptoms of early Parkinson's disease
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer